*Sponsored Content
An Expert View from Gaëtan Leblay, Managing Director, Janssen UK & Ireland.
It has been over two years since the COVID-19 pandemic was declared and our ’normal’ altered beyond recognition. The pandemic and subsequent lockdowns have shone a light on the inequality that exists, particularly in the healthcare sector. We have also been witness to the impact social restrictions have had on physical and mental health, and the need for tools to manage these adjustments in daily life. This shift has emphasized the growing need for a hybrid world, bridging the divide between digital and face-to-face interaction. As we look to living in the now, what have we learnt from this period and what can we bring to our new future?
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze